Literature DB >> 27973704

Crosstalk between Hippo signalling and miRNAs in tumour progression.

Nianshuang Li1, Chuan Xie1, Nonghua Lu1.   

Abstract

The Hippo signalling pathway co-ordinately modulates cell regeneration and organ size, and its deregulation contributes to tumorigenesis through many cellular processes, including overproliferation, apoptosis resistance and cell migration. Recent discoveries have shed new light on how microRNAs (miRNAs) are closely linked to the Hippo pathway in tumour progression. Hippo signalling has been reported to affect widespread miRNA biogenesis. In turn, several miRNAs regulate Hippo signalling, which contributes to carcinogenesis. This article will provide an overview of the crosstalk between Hippo signalling and miRNAs in the development of cancer and further appraise potential targets for therapeutic intervention.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  Hippo signalling pathway; miRNAs; tumour

Mesh:

Substances:

Year:  2017        PMID: 27973704     DOI: 10.1111/febs.13985

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  9 in total

1.  TAZ functions as a tumor suppressor in multiple myeloma by downregulating MYC.

Authors:  Stacy Grieve; Gabriel Wajnberg; Miranda Lees; Simi Chacko; Jackson Weir; Nicolas Crapoulet; Tony Reiman
Journal:  Blood Adv       Date:  2019-11-26

2.  MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis.

Authors:  Jiyoung Kim; Hyeryun Kwon; You Keun Shin; Gahyeon Song; Taebok Lee; Youngeun Kim; Wonyoung Jeong; Ukjin Lee; Xianglan Zhang; Gilyeong Nam; Hei-Cheul Jeung; Wantae Kim; Eek-Hoon Jho
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-01       Impact factor: 11.205

Review 3.  MicroRNAs, a Promising Target for Breast Cancer Stem Cells.

Authors:  Plabon Kumar Das; Mst Ayesha Siddika; Saharia Yeasmin Asha; Suraiya Aktar; Md Abdur Rakib; Jahan Ara Khanam; Suja Pillai; Farhadul Islam
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

Review 4.  YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance.

Authors:  Frank Szulzewsky; Eric C Holland; Valeri Vasioukhin
Journal:  Dev Biol       Date:  2021-01-08       Impact factor: 3.148

5.  Helicobacter pylori CagA promotes epithelial mesenchymal transition in gastric carcinogenesis via triggering oncogenic YAP pathway.

Authors:  Nianshuang Li; Yan Feng; Yi Hu; Cong He; Chuan Xie; Yaobin Ouyang; Stephen C Artim; Deqiang Huang; Yin Zhu; Zhijun Luo; Zhongming Ge; Nonghua Lu
Journal:  J Exp Clin Cancer Res       Date:  2018-11-22

6.  RHPCG: a database of the Regulation of the Hippo Pathway in Cancer Genome.

Authors:  Chengyu Wang; Fan Yang; Tingting Chen; Qi Dong; Zhangxiang Zhao; Yaoyao Liu; Bo Chen; Haihai Liang; Huike Yang; Yunyan Gu
Journal:  Database (Oxford)       Date:  2019-01-01       Impact factor: 3.451

7.  Association of variably methylated tumour DNA regions with overall survival for invasive lobular breast cancer.

Authors:  Medha Suman; Pierre-Antoine Dugué; Ee Ming Wong; JiHoon Eric Joo; John L Hopper; Tu Nguyen-Dumont; Graham G Giles; Roger L Milne; Catriona McLean; Melissa C Southey
Journal:  Clin Epigenetics       Date:  2021-01-18       Impact factor: 6.551

8.  Neuronal let-7b-5p acts through the Hippo-YAP pathway in neonatal encephalopathy.

Authors:  Vennila Ponnusamy; Richard T H Ip; Moumin A E K Mohamed; Paul Clarke; Eva Wozniak; Charles Mein; Leslie Schwendimann; Akif Barlas; Philippa Chisholm; Ela Chakkarapani; Adina T Michael-Titus; Pierre Gressens; Ping K Yip; Divyen K Shah
Journal:  Commun Biol       Date:  2021-09-30

9.  miR‑337‑3p inhibits gastric tumor metastasis by targeting ARHGAP10.

Authors:  Zishu Wang; Lun Yao; Yu Li; Bo Hao; Mingxi Wang; Junbin Wang; Wei Gu; Huihui Zhan; Guoquan Liu; Qiong Wu
Journal:  Mol Med Rep       Date:  2019-11-29       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.